The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Immunotherapy in myeloma: current strategies and future perspectives
Ajai Chari, Niels van de Donk and Saad Usmani
• 12 Sep 2019
Saad Usmani, MD, FACP, Levine Cancer Institute, Charlotte, NC, is joined by Ajai Chari, MD, PhD, Mount Sinai Medical Center, New York, NY and Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The speakers discuss different modalities of immunotherapy developed in myeloma, including monoclonal antibodies, myeloma microenvironment and immune signalling.
